We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.76B
AUM Growth
-$256M
Cap. Flow
-$351M
Cap. Flow %
-19.91%
Top 10 Hldgs %
49.94%
Holding
89
New
12
Increased
13
Reduced
24
Closed
14

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$19.2M
2
INSP icon
Inspire Medical Systems
INSP
+$17.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$12.3M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12M
5
WAT icon
Waters Corp
WAT
+$9.94M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$39.7M
2
DXCM icon
DexCom
DXCM
+$26.2M
3
EW icon
Edwards Lifesciences
EW
+$25.4M
4
BSX icon
Boston Scientific
BSX
+$18.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 95.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.04T
$265M 14.99%
298,643
– –
THC icon
2
Tenet Healthcare
THC
$16.8B
$98M 5.55%
589,409
– –
CYTK icon
3
Cytokinetics
CYTK
$11.2B
$92.8M 5.26%
1,757,192
– –
ABBV icon
4
AbbVie
ABBV
$448B
$79.8M 4.52%
403,861
– –
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$120B
$69.2M 3.92%
148,852
– –
ISRG icon
6
Intuitive Surgical
ISRG
$121B
$67.5M 3.82%
137,327
– –
MRK icon
7
Merck
MRK
$315B
$61.6M 3.49%
542,811
-53,450
-9% -$6.35M
HCA icon
8
HCA Healthcare
HCA
$82.5B
$50.7M 2.88%
124,840
– –
UHS icon
9
Universal Health Services
UHS
$9.04B
$49M 2.78%
213,983
– –
MCK icon
10
McKesson
MCK
$95.3B
$48.2M 2.73%
97,498
– –
ARGX icon
11
argenx
ARGX
$53.3B
$47.1M 2.67%
86,832
– –
UNH icon
12
UnitedHealth
UNH
$392B
$44.2M 2.5%
75,588
+6,150
+9% +$3.48M
ACHC icon
13
Acadia Healthcare
ACHC
$3.2B
$43.5M 2.47%
686,150
+265,986
+63% +$19.2M
AXSM icon
14
Axsome Therapeutics
AXSM
$12.3B
$42M 2.38%
467,427
– –
TMO icon
15
Thermo Fisher Scientific
TMO
$196B
$36.1M 2.05%
58,433
-5,217
-8% -$3.09M
DHR icon
16
Danaher
DHR
$127B
$34.9M 1.98%
125,515
– –
ICLR icon
17
Icon
ICLR
$12.9B
$33.5M 1.9%
116,532
– –
PEN icon
18
Penumbra
PEN
$12.4B
$32.3M 1.83%
166,261
-18,850
-10% -$3.56M
HUM icon
19
Humana
HUM
$47.7B
$32.3M 1.83%
101,954
-23,386
-19% -$8.32M
ELV icon
20
Elevance Health
ELV
$84.4B
$29.3M 1.66%
56,441
+1,191
+2% +$636K
AMGN icon
21
Amgen
AMGN
$198B
$29.1M 1.65%
90,297
+9,263
+11% +$3.03M
IQV icon
22
IQVIA
IQV
$33.1B
$26.5M 1.5%
111,854
– –
EW icon
23
Edwards Lifesciences
EW
$48.6B
$25.8M 1.46%
390,863
-349,397
-47% -$25.4M
BDX icon
24
Becton Dickinson
BDX
$42.2B
$24.5M 1.39%
101,680
-29,698
-23% -$6.96M
SYK icon
25
Stryker
SYK
$119B
$24.2M 1.37%
67,014
-47,283
-41% -$16.3M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q3 2024 Portfolio in Review

As of Q3 2024, PFM Health Sciences held 89 positions worth $1.76B, down 13% from $2.02B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

PFM Health Sciences withdrew a net $351M in Q3 2024, closing 14 positions and reducing 24 holdings. Its most notable exit was Centene, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 89% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Inspire Medical Systems worth $20.8M.

  • PFM Health Sciences's largest Q3 2024 buy was Inspire Medical Systems: 98,322 shares worth $20.8M.
  • PFM Health Sciences added most to Acadia Healthcare in Q3 2024, an estimated $19.2M increase.
  • PFM Health Sciences's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $25.4M.
  • PFM Health Sciences fully exited Centene in Q3 2024, selling an estimated $39.7M.
  • PFM Health Sciences's ten largest holdings make up 50% of its $1.76B portfolio in Q3 2024.
  • PFM Health Sciences opened 12 new positions and closed 14 in Q3 2024.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $1.76B.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.